Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial extension study examining safety, tolerability, pharmacokinetics, and activity of ATYR1940 in participants with facioscapulohumeral muscular dyst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy

Drugs mentioned

• ATYR1940

Snippet

Sponsor: aTyr Pharma, Inc. | Conditions: Facioscapulohumeral Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-18